The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes | NEJM
Misrepresenting Race — The Role of Medical Schools in Propagating Physician Bias | NEJM
Coronavirus (Covid-19) — NEJM
Rapid Diagnostic Testing for SARS-CoV-2 | NEJM
bjoern.brembs.blog » New England Journal of Medicine – and you thought Nature was expensive?
The New England Journal of Medicine - The new impact factor for NEJM is 54.42 (up 5%). Thank you to all of our authors, and to all of the patients who participate
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation | NEJM
2 021 NEJM Group U.S. Media Kit
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018 | NEJM
Gastroenterology articles: The New England Journal of Medicine
Aspergillus Infections | NEJM
Fixing Burnout Through Physician Input
Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma | NEJM
The Future of Public Health | NEJM
At NEJM, change at top offers chance to reshape the world's oldest medical journal
Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media | NEJM
Long-Term Complications in Youth-Onset Type 2 Diabetes | NEJM
NEJM — Race and Medicine
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD | NEJM
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
We Can Do Better — Improving the Health of the American People | NEJM
